| |
eGFR (CKD-EPI)
|
eGFR (MDRD)
|
|---|
|
Estimate
|
Standard error
|
P valuea
|
Estimate
|
Standard error
|
P valuea
|
|---|
|
Age
|
−0.907
|
0.055
|
<0.0001
|
−0.933
|
0.122
|
<0.0001
|
|
Sex
|
1.410
|
1.105
|
0.203
|
4.916
|
2.473
|
0.048
|
|
HBV DNA
|
0.211
|
0.214
|
0.325
|
0.502
|
0.573
|
0.382
|
|
ALT
|
−0.006
|
0.004
|
0.102
|
−0.014
|
0.009
|
0.146
|
|
AST
|
0.006
|
0.005
|
0.254
|
0.014
|
0.013
|
0.296
|
|
BUN
|
−0.492
|
0.107
|
<0.0001
|
−1.028
|
0.266
|
0.0001
|
|
ADV
|
−14.522
|
1.397
|
<0.0001
|
−27.352
|
2.759
|
<0.0001
|
|
ETV
|
1.595
|
1.430
|
0.266
|
1.963
|
3.640
|
0.590
|
|
PEG-IFN-α-2a
|
2.766
|
1.306
|
0.035
|
7.365
|
3.496
|
0.036
|
-
aResults from the linear mixed effects model for repeated measures. LdT therapy was set as reference
